Autopsy report · NCT00091156
Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Cause of deathSlow enrollment
“low accrual”
Life of this trial
- Registered 4 months after it had already started.
- 598 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Sponsor type
- University, hospital or other
- Conditions
- Lung Cancer
- Interventions
- gefitinib; adjuvant therapy
- Participants
- 598 (planned, not actual)
- Sites
- 28
- Countries
- Belgium, Cyprus, Egypt, Italy, Netherlands
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.